20 September, 2012
Dürr Dental streamlines business processes with IFS Applications 8
Dürr Dental AG, a German leading manufacturer of dental equipment, has selected IFS Applications 8 to replace its legacy software, accelerate information flows and establish uniform processes throughout the group. The contract includes software licenses and services worth approximately SKr 17 million.
Headquartered in Baden-Württemberg, Germany, Dürr Dental was running outdated, heavily customized legacy solutions that made standard upgrades impossible. Dürr Dental purchased IFS Applications 8 to minimize the number of interfaces, improve decision-making processes, introduce customer and supplier EDI and seamlessly integrate processes across the company.
“We chose IFS Applications 8 because it represents leading ERP technology and is ideal for a company of our size with global operations and plans for expansion.” Joachim Eppinger, CFO at Dürr Dental said. “We were also impressed by how well IFS understood our business and by the competence of its consultants. The reference visits and calls that we made to other IFS customers in our industry confirmed the suitability and capabilities of IFS Applications.”
“Signing Dürr Dental is further proof of the value and return on investment IFS offers companies in industrial manufacturing,” Peter Höhne, Vice President Sales & Marketing, IFS Central Europe said.“Our local presence and global reach give companies the peace of mind they require to change and grow, secure in the knowledge that their business software will support them every step of the way, regardless of where they operate.”
The IFS Applications 8 solution chosen includes components for manufacturing, distribution, maintenance, project management, sales and marketing, business analytics, financials, human resource management, document management, and quality management.
Industrial manufacturing is one of IFS’s targeted markets. IFS has a broad customer base in the industry, focusing on medium-sized to large manufacturers that need support for complex order-driven and mixed-mode manufacturing across the extended enterprise. With strong support for project management, engineering, advanced scheduling, product configuration, and after-sales support, IFS’s component-based business solutions are designed to help companies improve quality, contain costs, and improve their competitive position in manufacturing industry segments such as machinery, defense, fabricated metal products, and plastics. Industrial manufacturing companies also benefit from IFS’s lifecycle management solution, which goes beyond product lifecycle management (PLM) to provide better integration and management of three critical business areas—products, customers, and resources—throughout their lifecycles.
IFS Industrial Manufacturing customers include Chief Industries, Colfax Corporation, Kongskilde, Nolato Group, Bombardier, GEA Pharma Systems, PartnerTech, Stolle Machinery, Völkl, and Johnson Pump.
About Dürr Dental AG
Dürr Dental AG was founded in 1941 by Karl and Wilhelm Dürr from Gechingen, Germany. Its headquarters are now located in Bietigheim-Bissingen, Germany, where around 390 employees are engaged in production, research and development, and sales and marketing. The Dürr Dental Group currently has around 1,000 employees worldwide and a reported revenue of €200 million in 2011. The company is represented in 30 countries.
More information is available at www.duerrdental.de/
IFS is a public company (OMX STO: IFS) founded in 1983 that develops, supplies, and implements IFS Applications™, a component-based extended ERP suite built on SOA technology. IFS focuses on industries where any of four core processes are strategic: Service & asset management, manufacturing, supply chain and projects. The company has 2,000 customers and is present in approximately 60 countries with 2,800 employees in total. Net revenue in 2011 was SKr 2.6 billion.
Follow us on Twitter: @ifsworld
Visit the IFS Blogs on technology, innovation and creativity: http://blogs.ifsworld.com/
IFS discloses the information herein pursuant to the Financial Instruments Act (1991:980) and/or the Securities Markets Act (2007:528). The information was submitted for publication on September 20, 2012, at 3:45 p.m. CEST.